IL13RA2 and glioma: These findings demonstrate for the first time that IL13Rα2 expression in high-grade gliomas is a prognostic indicator of poor patient survival, and are in agreement with a recent finding that high IL13Rα2 expression is also associated with poor patient prognosis in colorectal cancer [38].